Giant Biogene Holding Co., Ltd.
2367
Rangering i aksjer
#5026
Giant Biogene Holding Co., Ltd. operates as an investment holding entity,... Giant Biogene Holding Co., Ltd. operates as an investment holding entity, primarily engaged in the research, development, production, and sale of beauty and wellness products based on bioactive materials throughout the People's Republic of China. The company also manufactures functional foods leveraging rare ginsenosides technology and provides medical devices. Its diverse product range, which includes specialized skincare, medical dressings, and nutritional supplements, is marketed predominantly under brand names such as Comfy, Collgene, Keyu, Kehen, Kefuping, Leeyen, SKIGIN, and Shengan. Established in 2000, Giant Biogene Holding Co., Ltd. maintains its headquarters in Xi'an, PRC.
Aksjekurs
$2.67
Markedsverdi
$2.84B
Endring (1 dag)
-6.09%
Endring (1 år)
-46.20%
Land
CN
Handel Giant Biogene Holding Co., Ltd. (2367)
Kategori
Consumer Defensive
P/S-forhold for Giant Biogene Holding Co., Ltd. (2367)
P/S-forhold per October 2026 TTM: 3.59
Ifølge Giant Biogene Holding Co., Ltd. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 3.59. Ved slutten av 2024 hadde selskapet et P/S-forhold på 8.47.
P/S-historikk for Giant Biogene Holding Co., Ltd. fra 2019 til 2026
P/S-forhold ved hvert års slutt
| År | P/S-forhold | Endre |
|---|---|---|
| 2026 (TTM) | 3.59 | -37.41% |
| 2025 | 5.73 | -32.35% |
| 2024 | 8.47 | -5.65% |
| 2023 | 8.98 | -26.69% |
| 2022 | 12.25 | -10.30% |
| 2021 | 13.65 | -27.03% |
| 2020 | 18.71 | -24.32% |
| 2019 | 24.72 | 0.00% |
P/S-forhold for lignende selskaper eller konkurrenter
| Selskap | P/S-forhold | Forskjell i P/S-forhold | Land |
|---|---|---|---|
| 4.28 | 19.25% |
US
|
|
| 4.52 | 26.10% |
FR
|
|
| 3.54 | -1.35% |
US
|
|
| 6.51 | 81.46% |
IN
|
|
| 2.50 | -30.41% |
US
|
